Filing Flows › Comparisons › PAHC vs INDV
Phibro Animal Health vs Indivior Pharmaceuticals: PAHC and INDV compared
Phibro Animal Health is the larger company: $387M of revenue in its latest quarter (Q1 FY27) against $356M for Indivior Pharmaceuticals (Q3 2026). Indivior Pharmaceuticals is growing faster (+13% against +6% a year earlier). Indivior Pharmaceuticals is more profitable, with an operating margin of 50.6% against 12.8%.
Where the money goes: PAHC and INDV
Phibro Animal Health (PAHC) · Q1 FY27
Phibro Animal Health, Q1 FY27: revenue $387M (+6% year over year), operating margin 12.8%, net earnings $29.5M, operating cash flow $26.1M. The chart follows the revenue to costs, profit and cash.
Indivior Pharmaceuticals (INDV) · Q3 2026
Indivior Pharmaceuticals, Q3 2026: revenue $356M (+13% year over year), operating margin 50.6%, net earnings $137M, operating cash flow $97.0M. The chart follows the revenue to costs, profit and cash.
| Phibro Animal Health (PAHC) | Indivior Pharmaceuticals (INDV) | |
|---|---|---|
| Latest quarter | Q1 FY27 | Q3 2026 |
| Revenue | $387M | $356M |
| Revenue growth, Y/Y | +6% | +13% |
| Gross margin | 33.2% | 85.7% |
| Operating margin | 12.8% | 50.6% |
| Net earnings | $29.5M | $137M |
| Net margin | 7.6% | 38.5% |
| Operating cash flow | $26.1M | $97.0M |
| Free cash flow | $7.3M | $83.0M |
| Market value | $1.3B | $4.4B |
| P/E | 13.2× | 10.1× |
| Analysts’ mean target | $47.00 | $49.50 |
Where the revenue comes from
Phibro Animal Health
- Animal Health: $293M (76%)
- Mineral Nutrition: $73.6M (19%)
- Performance Products: $20.2M (5%)
Questions
Which is bigger, Phibro Animal Health or Indivior Pharmaceuticals?
Phibro Animal Health is the larger company: $387M of revenue in its latest quarter (Q1 FY27) against $356M for Indivior Pharmaceuticals (Q3 2026).
Is Phibro Animal Health or Indivior Pharmaceuticals growing faster?
Indivior Pharmaceuticals is growing faster (+13% against +6% a year earlier).
Which is more profitable, Phibro Animal Health or Indivior Pharmaceuticals?
Indivior Pharmaceuticals is more profitable, with an operating margin of 50.6% against 12.8%.
More: Phibro Animal Health earnings · how Phibro Animal Health makes money · Indivior Pharmaceuticals earnings · how Indivior Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.